Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) ELISA Kits

The protein encoded by TNFRSF9 is a member of the TNF-receptor superfamily. Additionally we are shipping CD137 Antibodies (325) and CD137 Proteins (65) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
TNFRSF9 3604 Q07011
TNFRSF9 21942 P20334
TNFRSF9    
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top CD137 ELISA Kits at antibodies-online.com

Showing 5 out of 31 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Supplier Delivery Price Details
Mouse 10pg/mL 31.2-2000 pg/mL Mouse TNFRSF9/4-1BB PicoKine ELISA Kit standard curve 96 Tests Log in to see 4 to 6 Days
$369.00
Details
Human 10pg/mL 31.2-2000 pg/mL Human TNFRSF9/4-1BB PicoKine ELISA Kit standard curve 96 Tests Log in to see 4 to 6 Days
$369.00
Details
Rat
  96 Tests Log in to see 31 to 41 Days
$734.80
Details
Mouse < 18.75 pg/mL 31.2 pg/mL - 2000 pg/mL   100 Tests Log in to see 2 to 3 Days
$750.00
Details
Human
  96 Tests Log in to see 2 to 3 Days
$380.00
Details

More ELISA Kits for CD137 Interaction Partners

Human Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) interaction partners

  1. Cetuximab-mediated NK-cell expression of CD137 on tumor-infiltrating lymphocytes is dependent on FcgammaRIIIa polymorphism. In neoadjuvant cetuximab-treated patients with head and neck cancer, upregulation of CD137 by intratumoral, cetuximab-activated NK cells correlated with FcgammaRIIIa V/F polymorphism and predicted clinical response.

  2. In this study we systematically evaluated a series of CAR constructs targeting glypican-3 (GPC3 (show GPC3 ELISA Kits)), which is selectively expressed on several solid tumors. We compared GPC3 (show GPC3 ELISA Kits)-specific CARs that encoded CD3zeta (show CD247 ELISA Kits) (Gz) alone or with costimulatory domains derived from CD28 (show CD28 ELISA Kits) (G28z), 4-1BB (GBBz), or CD28 (show CD28 ELISA Kits) and 4-1BB (G28BBz).

  3. 4-1BB and 4-1BBL (show TNFSF9 ELISA Kits) qualify as markers for prediction of patients' course and represent a valuable screening target for patients with acute myeloid leukemia (show BCL11A ELISA Kits) at initial diagnosis.

  4. the role of CD137-CRDI (cysteine rich domain I) in the binding of CD137-CD137L (show TNFSF9 ELISA Kits) was further investigated.

  5. Egr2 (show EGR2 ELISA Kits)-driven cell surface proteins LAG-3 (show LAG3 ELISA Kits) and 4-1BB can identify dysfunctional tumor antigen-specific CD8 (show CD8A ELISA Kits)(+) TIL (show TLR1 ELISA Kits).

  6. Findings indicate that CD137 antigen is a useful marker that can be used for identifying Mycobacterium tuberculosis (Mtb)-reactive CD4 (show CD4 ELISA Kits)(+) T cells (Mtb-reactive CD4 (show CD4 ELISA Kits)(+) T cells) by flow cytometry.

  7. Anti-4-1BB single chain variable fragments enhanced surface CD69 (show CD69 ELISA Kits) expression and interleukin-2 (show IL2 ELISA Kits) production in stimulated CCRF-CEM cells which confirmed the agonistic effect of the selected single chain variable fragments. The data from this study have provided a rationale for further experiments involving the biological functions of anti-4-1BB single chain variable fragments in future studies.

  8. Studies suggest that adoptive T cell therapy and CD137 antigen offer much opportunity to raise the efficacy of current cancer immunotherapies.

  9. Triple costimulation via CD80 (show CD80 ELISA Kits), 4-1BB, and CD83 (show CD83 ELISA Kits) ligand elicits the long-term growth of Vgamma9Vdelta2 T cells in low levels of IL-2 (show IL2 ELISA Kits).

  10. These studies provide the first direct evidence that ligation of tumour necrosis factor (show TNF ELISA Kits) superfamily members and their cognate receptors is important for the control of viral lytic replication.

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) interaction partners

  1. fatty acid metabolism plays a crucial role in enhancing the cell cycle progression of anti-CD3 (show CD3E ELISA Kits)-activated CD8 (show CD8A ELISA Kits)(+) T cells in vitro and the anti-apoptotic effects of 4-1BB signaling on these cells.

  2. CD137 signaling activates the pro-angiogenic Smad1 (show SMAD1 ELISA Kits)/5 pathway, induces the phosphorylation of Smad1 (show SMAD1 ELISA Kits)/5 and nuclear translocation of p-Smad1 (show SMAD1 ELISA Kits)/5, which in turn promotes the expression and translocation of NFATc1 (show NFATC1 ELISA Kits). Blocking CD137 signaling with inhibitory anti-CD137 antibody could inhibit this activation and attenuated agonist anti-CD137 antibody-induced angiogenesis.

  3. the role of CD137-CRDI (cysteine rich domain I) in the binding of CD137-CD137L (show TNFSF9 ELISA Kits) was further investigated.

  4. Data indicate that anti-CD137 agonists can function as inhibitors of CD137L (show TNFSF9 ELISA Kits) signaling, resulting in the creation of tumor microenvironments unfavorable for tumor immune evasion.

  5. These studies reveal that the costimulatory effects of TLR1 (show TLR1 ELISA Kits)-TLR2 signaling in CD8 (show CD8A ELISA Kits)(+) T cells are in part mediated by 4-1BB and are important for mounting an effective antitumor immune response.

  6. This study discovers the 4-1BB pathway signaling enhances inflammatory response and promotes pulmonary fibrosis induced by crystalline silica.

  7. Constitutive interaction between 4-1BB and 4-1BBL (show TNFSF9 ELISA Kits) on murine LPS (show TLR4 ELISA Kits)-activated bone marrow dendritic cells masks detection of 4-1BBL (show TNFSF9 ELISA Kits) by TKS (show PTK6 ELISA Kits)-1 but not 19H3 antibody.

  8. results indicate that one important diabetogenic function of CD137 is to promote the expansion and accumulation of beta cell-autoreactive CD8 (show CD8A ELISA Kits) T cells, and in the absence of CD137 or its interaction with CD137 ligand, type 1 diabetes progression is suppressed

  9. High CD137 expression is associated with neoplasms.

  10. Ly6C, 4-1BB, and KLRG1 have roles in the activation of lamina propria lymphocytes in the small intestine in a mouse model of Crohn's disease

CD137 (TNFRSF9) Antigen Profile

Antigen Summary

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contributes to the clonal expansion, survival, and development of T cells. It can also induce proliferation in peripheral monocytes, enhance T cell apoptosis induced by TCR/CD3 triggered activation, and regulate CD28 co-stimulation to promote Th1 cell responses. The expression of this receptor is induced by lymphocyte activation. TRAF adaptor proteins have been shown to bind to this receptor and transduce the signals leading to activation of NF-kappaB.

Gene names and symbols associated with TNFRSF9

  • tumor necrosis factor receptor superfamily member 9 (TNFRSF9) antibody
  • TNF receptor superfamily member 9 (TNFRSF9) antibody
  • tumor necrosis factor receptor superfamily, member 9a (tnfrsf9a) antibody
  • tumor necrosis factor receptor superfamily, member 9 (Tnfrsf9) antibody
  • 4-1BB antibody
  • A930040I11Rik antibody
  • AA408498 antibody
  • AI325004 antibody
  • Cd137 antibody
  • CDw137 antibody
  • ILA antibody
  • Ly63 antibody
  • TNFRSF9 antibody
  • zgc:136557 antibody

Protein level used designations for TNFRSF9

tumor necrosis factor receptor superfamily, member 9 , tumor necrosis factor receptor superfamily member 9 , 4-1BB ligand receptor , CD137 antigen , T cell antigen ILA , T-cell antigen 4-1BB homolog , T-cell antigen ILA , homolog of mouse 4-1BB , induced by lymphocyte activation (ILA) , interleukin-activated receptor, homolog of mouse Ly63 , receptor protein 4-1BB , T-cell antigen 4-1BB , secreted CD137 antigen

GENE ID SPECIES
419365 Gallus gallus
520341 Bos taurus
608274 Canis lupus familiaris
678622 Danio rerio
708281 Macaca mulatta
746029 Pan troglodytes
100196937 Papio anubis
100348914 Oryctolagus cuniculus
3604 Homo sapiens
21942 Mus musculus
Selected quality suppliers for CD137 (TNFRSF9) ELISA Kits
Did you look for something else?